로딩 중…
지수 로딩 중…
Crinetics Pharmaceuticals, Inc.
CRNX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$35.87+0.34%
2026-06-18
Price Chart
Crinetics Pharmaceuticals, Inc.+17.61%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $3.78B |
| Revenue | $18M |
| Net Income | $-496M |
| Total Assets | $1.40B |
| Net Assets | $1.28B |
| Value | |
| P/B | 2.95x |
| P/S | 209.32x |
| FCF Yield | -11.09% |
| Profitability | |
| ROE | -38.76% |
| ROA | -35.42% |
| Op. Margin | -3020.32% |
| Revenue Growth | 2873.41% |
| Financial Health | |
| Debt Ratio | 9.42% |
| Total Debt | $48M |
| FCF | $-420M |
| Cash | $114M |
| Current Ratio | 18.60x |
| Performance | |
| 1Y Return | 17.61% |
| 1M Return | 2.66% |
| From 52W High | -38.14% |
| 1Y MDD | -42.21% |
| Trading | |
| Volume | 1,492,319 shares |
| Trading Value | $54M |
| Per Share | |
| EPS | $-4.95 |
| BPS | $10.55 |